Arcus Biosciences, Inc.
Arcus Biosciences, Inc. (RCUS) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · RCUS · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
38
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Arcus Biosciences, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
RCUS insider buying and selling by quarter
RCUS insider selling · RCUS insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · RCUS ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
RCUS executive sell shares · RCUS board member insider trading · RCUS insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 1, 2026 | Azoy Alexander CAO | Sale | 2,562 | $66K | Form 4 |
| Dec 16, 2025 | Ribas Antoni Director | Gift | 5,050 | — | Form 4 |
| May 11, 2026 | Goeltz II Robert C. CFO | Sale | 7,763 | $199K | Form 4 |
| Jan 23, 2026 | Markus Richard Chief Medical Officer | Award | 24,000 | — | Form 4 |
| Jan 23, 2026 | ROSEN TERRY J CEO · Director | Award | 79,000 | — | Form 4 |
| Jan 23, 2026 | Jaen Juan C. President | Award | 31,000 | — | Form 4 |
| Jan 23, 2026 | Tang Carolyn C. General Counsel | Award | 24,000 | — | Form 4 |
| Jan 23, 2026 | Goeltz II Robert C. CFO | Award | 24,000 | — | Form 4 |
| Jan 23, 2026 | Azoy Alexander CAO | Award | 21,050 | — | Form 4 |
| Jan 23, 2026 | Jarrett Jennifer COO | Award | 31,000 | — | Form 4 |
| Jan 8, 2026 | ROSEN TERRY J CEO · Director | Gift | 35,000 | — | Form 4 |
| Jan 5, 2026 | Jaen Juan C. President | Sale | 29,670 | $633K | Form 4 |
| Jan 5, 2026 | Jaen Juan C. President | Sale | 2,053 | $46K | Form 4 |
| Jan 5, 2026 | Jaen Juan C. President | Sale | 100 | $2K | Form 4 |
| Dec 31, 2025 | Goeltz II Robert C. CFO | Sale | 6,552 | $153K | Form 4 |
| Dec 30, 2025 | ROSEN TERRY J CEO · Director | Gift | 2,400 | — | Form 4 |
| Dec 16, 2025 | Tang Carolyn C. General Counsel | Sale | 7,658 | $168K | Form 4 |
| Dec 17, 2025 | Tang Carolyn C. General Counsel | Sale | 6,810 | $151K | Form 4 |
| Dec 16, 2025 | Markus Richard Chief Medical Officer | Sale | 5,052 | $111K | Form 4 |
| Dec 17, 2025 | Markus Richard Chief Medical Officer | Sale | 4,494 | $100K | Form 4 |
| Dec 16, 2025 | Azoy Alexander CAO | Sale | 2,376 | $52K | Form 4 |
| Dec 17, 2025 | Azoy Alexander CAO | Sale | 2,113 | $47K | Form 4 |
| Dec 18, 2025 | Azoy Alexander CAO | Sale | 4,343 | $97K | Form 4 |
| Dec 16, 2025 | Goeltz II Robert C. CFO | Sale | 6,702 | $147K | Form 4 |
| Dec 17, 2025 | Goeltz II Robert C. CFO | Sale | 5,960 | $132K | Form 4 |
Markus Richard
Chief Medical Officer
Date
Dec 16
Shares
5,052
Price
$21.88
Value
$111K
Markus Richard
Chief Medical Officer
Date
Dec 17
Shares
4,494
Price
$22.16
Value
$100K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About RCUS insider trading
RCUS insider trades
Arcus Biosciences, Inc. (RCUS) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Jaen Juan C. (President), Azoy Alexander (CAO), Jarrett Jennifer (COO). Over the past 12 months, 5 insiders have filed transactions with the SEC. RCUS insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Arcus Biosciences, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
RCUS insider trading · 5 questionsThe insiders of Arcus Biosciences, Inc. (RCUS) include executives and directors such as Jaen Juan C. (President), Azoy Alexander (CAO), Jarrett Jennifer (COO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026